You are here » Home » Companies » Company Overview » Concord Drugs Ltd

Concord Drugs Ltd.

BSE: 538965 Sector: Health care
NSE: N.A. ISIN Code: INE858L01010
BSE LIVE 15:40 | 23 May 50.15 -2.85
(-5.38%)
OPEN

50.35

HIGH

53.00

LOW

50.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 50.35
PREVIOUS CLOSE 53.00
VOLUME 9445
52-Week high 79.45
52-Week low 46.20
P/E 14.75
Mkt Cap.(Rs cr) 36
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 50.35
CLOSE 53.00
VOLUME 9445
52-Week high 79.45
52-Week low 46.20
P/E 14.75
Mkt Cap.(Rs cr) 36
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
Filter:

Concord Drugs Ltd. (CONCORDDRUGS) - Profit And Loss

Figures in Rs crore 2016 2015 2014
Income
Sales Turnover 50.68 40.02 33.95
Excise Duty 0.00 0.00 0.00
Net Sales 50.68 40.02 33.95
Other Income 0.20 0.37 0.12
Stock Adjustments 0.28 0.68 0.10
Total Income 51.16 41.07 34.17
Expenditure
Raw Materials 39.22 31.90 27.61
Power & Fuel Cost 0.77 0.34 0.50
Employee Cost 1.43 0.44 0.29
Other Manufacturing Expenses 0.45 0.42 1.46
Selling and Administration Expenses 0.78 0.56 0.96
Miscellaneous Expenses 0.06 0.02 0.00
less: Pre-operative Expenses Capitalised 0.00 0.00 0.00
Total Expenditure 42.71 33.68 30.82
Operating Profit 8.44 7.40 3.35
Interest 2.57 2.72 1.78
Gross Profit 5.87 4.68 1.57
Depreciation 2.91 3.63 1.14
Profit Before Tax 2.96 1.05 0.43
Tax 1.21 0.35 0.09
Net Profit 1.75 0.70 0.34